|
Secondary prevention
Citations 281-290 of 566 total displayed.
|
Past content
(since Feb 1999):
|
- Coronary Heart Disease
Effect of Atorvastatin on Risk of Recurrent Cardiovascular Events After an Acute Coronary Syndrome Associated With High Soluble CD40 Ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study
- Scott Kinlay, Gregory G. Schwartz, Anders G. Olsson, Nader Rifai, William J. Sasiela, Michael Szarek, Peter Ganz, Peter Libby for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators
Circulation 2004;110:386-391; published online before print as doi:10.1161/01.CIR.0000136588.62638.5E
[Abstract]
[Full text]
- Articles
Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention. Results From the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study
- Vincenzo Pasceri, Giuseppe Patti, Annunziata Nusca, Christian Pristipino, Giuseppe Richichi, Germano Di Sciascio on behalf of the ARMYDA Investigators
Circulation published July 26, 2004, doi:10.1161/01.CIR.0000137828.06205.87
[Abstract]
- Arrhythmia/Electrophysiology
Heart Failure and Sudden Death in Patients With Tachycardia-Induced Cardiomyopathy and Recurrent Tachycardia
- Pamela Nerheim, Sally Birger-Botkin, Lubna Piracha, and Brian Olshansky
Circulation 2004;110:247-252; published online before print as doi:10.1161/01.CIR.0000135472.28234.CC
[Abstract]
[Full text]
- Coronary Heart Disease
Regression of Coronary Atherosclerosis by Simvastatin: A Serial Intravascular Ultrasound Study
- Lisette Okkels Jensen, Per Thayssen, Knud Erik Pedersen, Steen Stender, and Torben Haghfelt
Circulation 2004;110:265-270; published online before print as doi:10.1161/01.CIR.0000135215.75876.41
[Abstract]
[Full text]
- Articles
Fish Intake and Risk of Incident Atrial Fibrillation
- Dariush Mozaffarian, Bruce M. Psaty, Eric B. Rimm, Rozenn N. Lemaitre, Gregory L. Burke, Mary F. Lyles, David Lefkowitz, and David S. Siscovick
Circulation published July 19, 2004, doi:10.1161/01.CIR.0000138154.00779.A5
[Abstract]
- Articles
Temporal Trends in Coronary Heart Disease Mortality and Sudden Cardiac Death From 1950 to 1999. The Framingham Heart Study
- Caroline S. Fox, Jane C. Evans, Martin G. Larson, William B. Kannel, and Daniel Levy
Circulation published July 19, 2004, doi:10.1161/01.CIR.0000136993.34344.41
[Abstract]
- Articles
Effect of Atorvastatin on Risk of Recurrent Cardiovascular Events After an Acute Coronary Syndrome Associated With High Soluble CD40 Ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study
- Scott Kinlay, Gregory G. Schwartz, Anders G. Olsson, Nader Rifai, William J. Sasiela, Michael Szarek, Peter Ganz, Peter Libby for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
Circulation published July 19, 2004, doi:10.1161/01.CIR.0000136588.62638.5E
[Abstract]
- Articles
Regression of Coronary Atherosclerosis by Simvastatin. A Serial Intravascular Ultrasound Study
- Lisette Okkels Jensen, Per Thayssen, Knud Erik Pedersen, Steen Stender, and Torben Haghfelt
Circulation published July 6, 2004, doi:10.1161/01.CIR.0000135215.75876.41
[Abstract]
- Reviews: Current Perspectives
Principles for National and Regional Guidelines on Cardiovascular Disease Prevention: A Scientific Statement From the World Heart and Stroke Forum
- Sidney C. Smith, Jr, Rod Jackson, Thomas A. Pearson, Valentin Fuster, Salim Yusuf, Ole Faergeman, David A. Wood, Michael Alderman, John Horgan, Philip Home, Marilyn Hunn, and Scott M. Grundy
Circulation 2004;109:3112-3121, doi:10.1161/01.CIR.0000133427.35111.67
[Full text]
- Articles
Heart Failure and Sudden Death in Patients With Tachycardia-Induced Cardiomyopathy and Recurrent Tachycardia
- Pamela Nerheim, Sally Birger-Botkin, Lubna Piracha, and Brian Olshansky
Circulation published June 28, 2004, doi:10.1161/01.CIR.0000135472.28234.CC
[Abstract]
|
|
